Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07283861 · ClinicalTrials.gov registry record · NA
Axoguard HA Plus Nerve Protector to Reduce Post-operative Neck and Shoulder Dysfunction in Patients Undergoing Neck Dissection
A NA study of Head and Neck Cancer and Neck Dissection, sponsored by Matthew Spector.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT07283861 is a NA study of Head and Neck Cancer and Neck Dissection that is actively recruiting participants, run by Matthew Spector. The registered enrollment target is 90 participants, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07283861, a NA study of Head and Neck Cancer and Neck Dissection, is actively recruiting participants, sponsored by Matthew Spector.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
In this prospective study, patients with head and neck cancers undergoing neck dissection will have the nerve to the shoulder wrapped with the Axoguard HA+ Nerve Protector at time of surgery. In these patients, the presence and severity of neck and shoulder dysfunction on the operated side will be assessed approximately twelve months post-operatively. The investigators hypothesize that shoulder nerve wrapping with the Axoguard HA+ Nerve Protector will lead to clinically meaningful improvement of shoulder function.
Conditions Studied
Interventions
- DEVICE Spinal Accessory Nerve Protection utilizing Axoguard HA+
Study Locations (1)
Pennsylvania
- UPMC Presbyterian Shadyside - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-12-09 |
| Est. Completion | 2028-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07283861
The ClinicalTrials.gov registry entry for NCT07283861 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (65% lower). The listed sponsor is Matthew Spector, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which Spinal Accessory Nerve Protection utilizing Axoguard HA+ is the first listed.
NCT07283861 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07283861 about?
NCT07283861 is a clinical study titled "Axoguard HA Plus Nerve Protector to Reduce Post-operative Neck and Shoulder Dysfunction in Patients Undergoing Neck Dissection". In this prospective study, patients with head and neck cancers undergoing neck dissection will have the nerve to the shoulder wrapped with the Axoguard HA+ Nerve Protector at time of surgery. In these patients, the presence and severity of neck and shoulder dysfunction on the operated side will be a...
What is the current status of trial NCT07283861?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-12-09. Estimated completion is 2028-01.
What conditions does trial NCT07283861 study?
This clinical trial studies the following conditions: Head and Neck Cancer, Neck Dissection.
What interventions are being tested in trial NCT07283861?
The interventions under investigation include: Spinal Accessory Nerve Protection utilizing Axoguard HA+ (DEVICE).
Who is sponsoring clinical trial NCT07283861?
This trial is sponsored by Matthew Spector, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07283861 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
RECRUITING · NA
-
PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.